Congress Looks to Beef up Agency’s Power to Withdraw Unproven AA Drugs
The House Energy and Commerce Committee is considering a pair of rival bills, one Democratic and one Republican, to reform the AA process.
Recent Headlines
Recent Headlines
Subscribe today for access to
Articles and Reports
Malpractice Premiums Rise but Medicare Reimbursement Doesn’t
...
Already a member? Log in here
How to Comply with Medicare Signature & Documentation Requirements
...
Already a member? Log in here
A roundup of recent cases and enforcement actions involving the diagnostics industry
...
Already a member? Log in here
Genomic Testing Utilization Is Low & Geographically Inconsistent but Not Just Due to Payor Coverage
...
Already a member? Log in here
Using Waivers to Avoid Getting Sued for COVID-19 Infections
...
Already a member? Log in here
Labs Lost Less & Will Recover More than Other Healthcare Sectors, Says New Report
...
Already a member? Log in here
Lab’s Duty to Protect Returning Employees from COVID-19 Discrimination and Harassment
...
Already a member? Log in here
Agency to Provide Emergency Clearance for Multi-Analyte Respiratory Panels
...
Already a member? Log in here
New Guidelines Advise Against Using Polygenetic Risk Scores for Routine Patient Management
...
Already a member? Log in here
COVID-19 Retesting Should Be Pushed Back to 4 Weeks to Give Virus Ample Time to Shed
...
Already a member? Log in here
Arizona Lab’s 20-Year Quest to Regain CLIA Certification Comes Up Empty
...
Already a member? Log in here
- « Previous
- 1
- 2
- 3
- 4
- Next »